v3.26.1
Restatement of Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2026
Restatement of Prior Period Financial Statements [Abstract]  
Schedule of Audited Condensed Consolidated Balance Sheet

Audited Condensed Consolidated Balance Sheet

in thousands

 

December 31,
2025
Previously
Reported

 

Adjustments

 

December 31,
2025
As Corrected

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Prepaid expenses and other current assets

 

$

59

 

 

$

(11

)

 

$

48

 

Note receivable – related party

 

 

4,167

 

 

 

(4,167

)

 

 

 

Total current assets

 

 

17,404

 

 

 

(4,179

)

 

 

13,226

 

Total assets

 

$

26,670

 

 

$

(4,179

)

 

$

22,491

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

$

 

 

$

(2,329

)

 

$

(2,329

)

Accumulated deficit

 

 

(676,957

)

 

 

(1,850

)

 

 

(678,807

)

Total members’ deficit

 

 

(650,689

)

 

 

(4,179

)

 

 

(654,868

)

Total liabilities and members’ deficit

 

$

26,670

 

 

$

(4,179

)

 

$

22,491

 

Schedule of Unaudited Condensed Consolidated Statements of Operations

Unaudited Condensed Consolidated Statements of Operations

in thousands

 

March 31,
2025

Previously
Reported

 

Adjustments

 

March 31,
2025
As Corrected

General and administrative expenses(1)

 

$

1,851

 

 

$

827

 

 

$

2,678

 

Loss from operations

 

 

(1,975

)

 

 

(827

)

 

 

(2,802

)

Provision for credit losses

 

 

(1,310

)

 

 

840

 

 

 

(470

)

Total other expense, net

 

 

(16,035

)

 

 

840

 

 

 

(15,195

)

Loss before income taxes

 

 

(18,010

)

 

 

13

 

 

 

(17,996

)

Net loss

 

$

(18,010

)

 

$

13

 

 

$

(17,996

)

(1)      The Company has combined certain captions that were previously disaggregated within operating expenses.

Schedule of Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit

 

Additional
Paid-in
Capital

 

Accumulated
Deficit

 

Total
Stockholders’
Deficit

As Previously Reported

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2024

 

$

 

 

$

(58,962

)

 

$

(49,374

)

Net loss

 

$

 

 

$

(18,009

)

 

$

(18,009

)

Balance March 31, 2025

 

$

 

 

$

(76,971

)

 

$

(66,134

)

   

 

 

 

 

 

 

 

 

 

 

 

Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2024

 

$

261

 

 

$

(1,931

)

 

$

(1,625

)

Investor loan advances and deemed contributions

 

$

(853

)

 

$

 

 

$

(853

)

Net loss

 

$

 

 

$

13

 

 

$

13

 

Balance March 31, 2025

 

$

(592

)

 

$

(1,918

)

 

$

(2,465

)

   

 

 

 

 

 

 

 

 

 

 

 

As Corrected

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2024

 

$

261

 

 

$

(60,893

)

 

$

(51,000

)

Investor loan advances and deemed contributions

 

 

(853

)

 

 

 

 

 

(853

)

Net loss

 

 

 

 

 

(17,996

)

 

 

(17,996

)

Balance March 31, 2025

 

$

(592

)

 

$

(78,889

)

 

$

(68,599

)

Schedule of Unaudited Condensed Consolidated Statement of Cash Flows

Unaudited Condensed Consolidated Statement of Cash Flows

in thousands

 

March 31,
2025
Previously
Reported

 

Adjustments

 

March 31,
2025
As Corrected

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(18,010

)

 

$

13

 

 

$

(17,996

)

Allowance for credit losses

 

 

1,310

 

 

 

(840

)

 

 

470

 

Investor expenses incurred on behalf of Company

 

 

 

 

 

827

 

 

 

827

 

Net cash used in operating activities

 

 

(2,063

)

 

 

 

 

 

(2,063

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Advance – note receivable related parties

 

 

(1,680

)

 

 

1,680

 

 

 

 

Net cash used in investing activities

 

 

(2,154

)

 

 

1,680

 

 

 

(474

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Constructive disbursements to related party

 

 

 

 

 

(1,680

)

 

 

(1,680

)

Net cash provided by financing activities

 

 

5,335

 

 

 

(1,680

)

 

 

3,655